Has Pradeep Chaganti, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,345 in general payments to Pradeep Chaganti, MD across 77 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Pradeep Chaganti, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Pradeep Chaganti, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Pradeep Chaganti, MD

Nephrology · Dalton, GANPI 1255680575

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.3% of the total across 77 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by OPKO Pharmaceuticals, LLC at 25.6% of the total. Reporting peaked in 2020 at $611 and has fallen 91.8% since, to $50 in 2024. That places this record below the midpoint for nephrology clinicians in GA, where the typical reported total is $1,554.

$1,345in general payments, 2019–2025

Across 77 payments — averaging $17.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

OPKO Pharmaceuticals, LLC$344
AstraZeneca$272
Akebia Therapeutics Inc$132
Amgen$128
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$100
Fresenius USA Marketing, Inc.$86
plus $281 from 10 others

What the payments were for

Food & beverage$1,29596%
Education$494%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
OPKO Pharmaceuticals, LLC	23	$344
AstraZeneca	14	$272
Akebia Therapeutics Inc	7	$132
Amgen	6	$128
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$100
Fresenius USA Marketing, Inc.	5	$86
Vifor Pharma, Inc.	2	$44
AMAG Pharmaceuticals, Inc.	3	$43
AbbVie(2 entities)	3	$43
Genentech USA, Inc.	2	$32
Mallinckrodt Enterprises LLC	1	$25
Johnson & Johnson	1	$24
Otsuka America Pharmaceutical, Inc.	1	$23
Travere Therapeutics, Inc.	6	$18
E.r. Squibb & Sons, L.L.C.	1	$16
Novartis	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

LifeVest$100

How this compares

$1,345 in reported general payments places this provider in the 45th percentile of 388 nephrology providers in Georgia.

See all nephrology providers in Georgia →

Medicare billing

Part B allowed, 2024

$97,711

Medicare patients

342

Services billed

935

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	12	$6,384
Hydralazine Hcl	12	$109
Metoprolol Succinate	17	$97
Pantoprazole Sodium	15	$91
Atorvastatin Calcium	21	$83
Prednisone	26	$67
Cephalexin	23	$64
Levofloxacin	19	$51
Furosemide	20	$49
Amlodipine Besylate	21	$48
Oxycodone Hcl	11	$26

Paid to pharmacies, not to this prescriber.

Other nephrology in Dalton

Frank NewbyDalton$8K
Rafael DuchesneDalton$8K
Sagar PanseMacon$542K
Sheldon ShoreAtlanta$474K
James TumlinLawrenceville$434K
Salvatore ChillemiMarietta$287K
Christina KleinAtlanta$137K
Mary MuonekeAtlanta$119K
Don WilliamsonAugusta$104K
Frederic Rahbari OskouiAtlanta$88K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →